Related Experiment Video

Updated: May 11, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease

Gavin Hudson1, Mike Nalls, Jonathan R Evans

  • 1Wellcome Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.

Neurology
|May 7, 2013
PubMed
Abstract

Insights

Mitochondrial DNA (mtDNA) variants show a reduced risk of Parkinson disease (PD), particularly with haplogroup JT. This study clarifies inconsistent findings and suggests mtDNA haplogroups may influence PD risk through antagonistic pleiotropy.

Area of Science:

  • Genetics
  • Neuroscience
  • Mitochondrial Biology

Background:

  • Previous research on mitochondrial DNA (mtDNA) and Parkinson disease (PD) has yielded inconsistent results.
  • Understanding the role of mtDNA variants in PD pathogenesis is crucial for identifying risk factors.

Purpose of the Study:

  • To resolve inconsistencies in previous studies linking mtDNA to PD risk.
  • To determine the significant role of specific mtDNA variants and haplogroups in PD development.

Main Methods:

  • A two-stage genetic association study involving 3,074 PD cases and 5,659 controls.
  • Analysis of 138 common mtDNA variants.
  • Subsequent meta-analysis combining data from 6,140 PD cases and 13,280 controls.

Main Results:

  • Mitochondrial DNA variants m.2158T>C and m.11251A>G were associated with a reduced risk of PD.
  • Super-haplogroup JT showed a protective association with PD.
  • Meta-analysis revealed reduced PD risk with haplogroups J, K, T, and JT, and increased risk with super-haplogroup H.

Conclusions:

  • The study confirms a reduced risk of PD associated with super-haplogroup JT, specifically at the J1b level.
  • Inconsistencies in prior research are explained by sampling effects.
  • Antagonistic pleiotropy between mtDNA haplogroups may influence PD risk and survival post-sepsis.

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...